{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T04:36:47Z","timestamp":1767847007567,"version":"3.49.0"},"reference-count":19,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,10,27]],"date-time":"2020-10-27T00:00:00Z","timestamp":1603756800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,10,27]],"date-time":"2020-10-27T00:00:00Z","timestamp":1603756800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Complement Med Ther"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>The usage and attitudes towards medical marijuana in Cystic Fibrosis (CF) patients is unknown. Through the use of a survey we aim to clarify rates and reasons for use.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>An anonymous survey was sent out to six centers in the Mid-Atlantic region of the United States. Use of and reason for medical marijuana was assessed, along with attitudes of the perceived utility of medical marijuana.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>A total of 637 surveys were sent out, and 193 surveys were returned (30.3% return rate). Three did not give consent, and one was empty, for a total of 189 completed surveys. 31 subjects (16.5%) reported having used marijuana for medical purposes in their lifetime, with 29 (15.4%) of these in the past year. The most used forms were edible and vaporized. The most common indications for usage were pain and stress. 28 out of 31 found marijuana to be a great deal effective for their symptoms. 21 of the 31 rated marijuana very important or important to their health. There were two reported side effects, both mild. Of 156 subjects who responded to the question if they would be interested in medical marijuana if available, 72 (46.2%) replied yes.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>The use of marijuana for medical reasons was 15.4% in the past year in this sample CF population, although more expressed interest if it was available through prescription. Side effects were rare. CF physicians are going to have to familiarize themselves with advantages and disadvantages of medical marijuana as there is a great deal of interest within the community, and legalization becomes more common.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12906-020-03116-x","type":"journal-article","created":{"date-parts":[[2020,10,27]],"date-time":"2020-10-27T11:03:50Z","timestamp":1603796630000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Use of medical marijuana in cystic fibrosis patients"],"prefix":"10.1186","volume":"20","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0623-1913","authenticated-orcid":false,"given":"Michael J.","family":"Stephen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jared","family":"Chowdhury","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luis Arzeno","family":"Tejada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert","family":"Zanni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Denis","family":"Hadjiliadis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,10,27]]},"reference":[{"key":"3116_CR1","doi-asserted-by":"publisher","first-page":"1289","DOI":"10.1016\/j.jval.2019.05.005","volume":"22","author":"KE Hutchison","year":"2019","unstructured":"Hutchison KE, Bidwell LC, Ellingson JM, Bryan AD. Cannabis and Health Research: rapid Progress requires innovative research designs. Value Health. 2019;22:1289\u201394.","journal-title":"Value Health"},{"key":"3116_CR2","doi-asserted-by":"publisher","first-page":"2456","DOI":"10.1001\/jama.2015.6358","volume":"24","author":"PF Whiting","year":"2015","unstructured":"Whiting PF, Wolff RF, Deshpande S, et al. Cannabinoids for medical use: a systemic review and meta-analysis. JAMA. 2015;24:2456\u201373.","journal-title":"JAMA"},{"key":"3116_CR3","unstructured":"\"Cystic Fibrosis Foundation Patient Registry2018 Annual Data Report Bethesda, Maryland \u00a92019 Cystic Fibrosis Foundation.\" https:\/\/www.cff.org\/Research\/Researcher-Resources\/Patient-Registry\/2018-Patient-Registry-Annual-Data-Report.pdf."},{"key":"3116_CR4","doi-asserted-by":"publisher","first-page":"P5","DOI":"10.1164\/rccm.1963P5","volume":"196","author":"American Thoracic Society Patient Education Series","year":"2017","unstructured":"American Thoracic Society Patient Education Series. Smoking marijuana and the lungs. Am J Respir Crit Care Med. 2017;196:P5\u20136.","journal-title":"Am J Respir Crit Care Med"},{"key":"3116_CR5","doi-asserted-by":"crossref","unstructured":"Stout SM, Cimino NM. Exogenous cannabinoids as substrates, inhibitors, and inducers of human drug metabolizing enzymes: a systematic review. Drug Metab Rev. 2014;46:86\u201395.","DOI":"10.3109\/03602532.2013.849268"},{"key":"3116_CR6","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1016\/S0022-3476(87)80090-2","volume":"111","author":"RC Stern","year":"1987","unstructured":"Stern RC, Byard PJ, Tomashefski JF, Doershuk CF. Recreational use of psychoactive drugs by patients with cystic fibrosis. J Pediatr. 1987;111:293\u20139.","journal-title":"J Pediatr"},{"key":"3116_CR7","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1542\/peds.101.2.250","volume":"101","author":"MT Britto","year":"1998","unstructured":"Britto MT, Garrett JM, Dugliss MA, et al. Risky behavior in teens with cystic fibrosis or sickle cell disease: a multicenter study. Pediatrics. 1998;101:250\u20136.","journal-title":"Pediatrics"},{"key":"3116_CR8","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.jcf.2003.12.001","volume":"3","author":"F Festini","year":"2004","unstructured":"Festini F, Ballarin S, Codamo T, et al. Prevalence of pain in adults with cystic fibrosis. J Cyst Fibros. 2004;3:51\u20137.","journal-title":"J Cyst Fibros"},{"key":"3116_CR9","doi-asserted-by":"publisher","first-page":"282","DOI":"10.7326\/M18-0810","volume":"169","author":"S Keyhani","year":"2018","unstructured":"Keyhani S, Steigerwald S, Ishida J, et al. Risks and benefits of marijuana use, a National Survey of U.S. adults. Ann Intern Med. 2018;169:282\u201390.","journal-title":"Ann Intern Med"},{"key":"3116_CR10","doi-asserted-by":"publisher","first-page":"1235","DOI":"10.1001\/jamapsychiatry.2015.1858","volume":"72","author":"DS Hasin","year":"2015","unstructured":"Hasin DS, Saha TD, Kerridge BT, et al. Prevalence of marijuana use disorders in the United States between 2001-2002 and 2012-2013. JAMA Psychiatry. 2015;72:1235\u201342.","journal-title":"JAMA Psychiatry"},{"key":"3116_CR11","first-page":"1","volume":"16","author":"JJ Carney","year":"2019","unstructured":"Carney JJ, Hwang A, Heckmann N, et al. Characteristics of marijuana us among orthopedic patients. Orthopedics. 2019;16:1\u20137.","journal-title":"Orthopedics"},{"key":"3116_CR12","doi-asserted-by":"publisher","first-page":"100497","DOI":"10.1016\/j.gore.2019.100497","volume":"30","author":"EA Blake","year":"2019","unstructured":"Blake EA, Ross M, Ihenacho U, et al. Non-prescription cannabis use for symptom management amongst women with gynecologic malignancies. Gynecol Oncol Rep. 2019;30:100497.","journal-title":"Gynecol Oncol Rep"},{"key":"3116_CR13","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1089\/108729104323038892","volume":"18","author":"MD Furler","year":"2004","unstructured":"Furler MD, Einarson TR, Millson M, et al. Medicinal and recreational marijuana use by patients infected with HIV. AIDS Patient Care STDs. 2004;18:215\u201328.","journal-title":"AIDS Patient Care STDs"},{"key":"3116_CR14","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/j.jns.2008.06.037","volume":"273","author":"JE Martinez-Rodriguez","year":"2008","unstructured":"Martinez-Rodriguez JE, Munteis E, Carreno M, et al. Cannabis use in Spanish patients with multiple sclerosis: Fulfilment of patients' expectations? J Neurol Sci. 2008;273:103\u20137.","journal-title":"J Neurol Sci"},{"key":"3116_CR15","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1177\/1352458506070947","volume":"12","author":"MS Chong","year":"2006","unstructured":"Chong MS, Wolff K, Wise K, et al. Cannabis use in patients with multiple sclerosis. Mult Scler. 2006;12:646\u201351.","journal-title":"Mult Scler"},{"key":"3116_CR16","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2019.11936","volume":"2","author":"H Dai","year":"2019","unstructured":"Dai H, Richter KP. A National Survey of marijuana use among US adults with medical conditions, 2016-2017. JAMA Netw Open. 2019;2:e1911936.","journal-title":"JAMA Netw Open"},{"key":"3116_CR17","doi-asserted-by":"publisher","first-page":"1262","DOI":"10.1093\/schbul\/sbw003","volume":"42","author":"A Marconi","year":"2016","unstructured":"Marconi A, Di Forti M, Lewis CM, Murray RM, Vassos E. Metaanalysis of the association between the level of cannabis use and risk of psychosis. Schizophr Bull. 2016;42:1262\u20139.","journal-title":"Schizophr Bull"},{"key":"3116_CR18","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1513\/AnnalsATS.201212-127FR","volume":"10","author":"DP Tashkin","year":"2013","unstructured":"Tashkin DP. Effects of marijuana smoking on the lung. Ann Am Thorac Soc. 2013;10:239\u201347.","journal-title":"Ann Am Thorac Soc"},{"key":"3116_CR19","doi-asserted-by":"publisher","first-page":"1142","DOI":"10.15585\/mmwr.mm6849e1","volume":"68","author":"MJ Lozier","year":"2019","unstructured":"Lozier MJ, Wallace B, Anderson K, et al. Update: demographic, product, and substance-use characteristics of hospitalized patients in a Nationwide outbreak of E-cigarette, or Vaping, product use\u2013associated lung injuries \u2014 United States, December 2019. MMWR Morb Mortal Wkly Rep. 2019;68:1142\u20138.","journal-title":"MMWR Morb Mortal Wkly Rep"}],"container-title":["BMC Complementary Medicine and Therapies"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12906-020-03116-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12906-020-03116-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12906-020-03116-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,10,26]],"date-time":"2021-10-26T23:07:48Z","timestamp":1635289668000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccomplementalternmed.biomedcentral.com\/articles\/10.1186\/s12906-020-03116-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10,27]]},"references-count":19,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["3116"],"URL":"https:\/\/doi.org\/10.1186\/s12906-020-03116-x","relation":{},"ISSN":["2662-7671"],"issn-type":[{"value":"2662-7671","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,10,27]]},"assertion":[{"value":"17 May 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 October 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 October 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Appropriate ethics approval for this study was obtained at Drexel University, Morristown Medical Center, Robert Wood Johnson Barnabas Health, Hershey Medical Center, Barnabas Medical Center, and the Hospital of the University of Pennsylvania.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not Applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"323"}}